Krishna Institute of Medical Sciences has successfully closed its Qualified Institutions Placement (QIP) on June 19, 2026, allotting 19,867,549 equity shares to eligible qualified institutional buyers at a price of ₹755 per share. The allotment includes a premium of ₹753 per equity share and incorporates a discount of ₹16.73 per share, equivalent to 2.17% of the floor price of ₹771.73. The issue, which opened on June 16, 2026, was conducted under the provisions of Chapter VI of the SEBI ICDR Regulations and Sections 42 and 62(1)(c) of the Companies Act, 2013.

The Finance & Investment Committee approved the closure of the issue period and finalized the allocation during a meeting held on June 19, 2026. The committee determined the issue price in consultation with the book running lead managers, applying the permitted discount on the floor price calculated under Regulation 176(1) of the SEBI ICDR Regulations. The trading window for designated persons, which was closed since the issue opening, will reopen 48 hours after the determination of the issue price.

Issue Details

The placement document dated June 19, 2026, has been filed with the stock exchanges and is available on the company's website. The company has approved the issuance of refund intimation letters to bidders entitled to refunds. The allotment was finalized following the receipt of application forms and funds in the escrow account from eligible buyers.

The company had previously secured board approval on March 11, 2026, and shareholder consent via postal ballot on April 15, 2026, to raise capital through this issuance.

Krishna Institute of Medical Sciences Limited has scheduled an Extraordinary General Meeting (EGM) on July 9, 2026, to seek shareholder approval for the preferential allotment of 77,02,182 warrants to its promoter and promoter group. The issuance, aggregating to ₹5,99,99,99,778, was approved by the Board of Directors on June 13, 2026. The warrants are fully convertible into equity shares with a face value of ₹2 each at a price of ₹779, including a premium of ₹777. The EGM will be conducted through video conferencing at 4:00 PM IST.

The warrants will be issued to Dr. Abhinay Bollineni, Mr. Adwik Bollineni, and Bharas Ventures LLP. Dr. Abhinay Bollineni and Mr. Adwik Bollineni will receive 32,09,242 warrants each, while Bharas Ventures LLP will receive 12,83,698 warrants. The issue price is determined in accordance with Regulation 164 of the SEBI ICDR Regulations and the company's articles of association, based on a valuation report from a registered valuer. The relevant date for determining the issue price is June 9, 2026.

Details of the Preferential Allotment

The following table outlines the allotment details for each allottee under the preferential warrant issuance:

Warrant Terms and Conditions

The warrants are exercisable in one or more tranches within 18 months from the date of allotment. An amount equivalent to 25% of the warrant issue price is payable at the time of subscription, with the balance 75% due upon conversion. If the warrants are not exercised within the 18-month period, the entitlement will lapse, and any amount paid will be forfeited.

The company stated that the fund raising aims to bolster its capital base. The trading window for designated persons and their immediate relatives remains closed until 48 hours after the board meeting's conclusion. Shareholders can cast their votes through remote e-voting from July 6, 2026, to July 8, 2026.